In the immune microenvironment of HCC, anti-PD1 antibody binds to PD1 on the surface of T cells and anti-PDL1 antibody binds to PDL1 on the surface of cancer cells, which will activate T cells and eliminate tumors. This evidence concerns the gene CD274 and hepatocellular carcinoma.